Article: P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience

€3.03

SKU: product-article-15510 Category: General

Description
Reviews (0)

Description

P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience

Reviews

There are no reviews yet.

Be the first to review “Article: P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience”

You must be logged in to post a review.

Top

Article: P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience

Description

Reviews

Related products

Article: Highlights in urologic cancer

Article: INTRODUCTION

Article: Highlights in melanoma

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma